Evaluation of mediastinal LNs in lung cancer using Discovery MR750 3.0T eDWI

Evaluation of mediastinal LNs in lung cancer using Discovery MR750 3.0T eDWI - MRI study of mediastinal lymphadenopathies

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006176

Enrollment

Registered

2011-08-22

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Preoperative lung cancer patients Perform an MRI prior to surgery for lung cancer, 30 patients were deemed operable by CT scan. EBUS can be enforced if the evaluation of hilar and mediastinal lymph nodes by MRI prior to enforcement as applied to artifacts EBUS. Control group Five healthy volunteers with no history of lung cancer.

Exclusion criteria

Exclusion criteria: Exclusion criteria To patients who meet any of the following criteria. 1) Patients with a history of lung cancer surgery. 2) Patients with cardiac arrhythmias. 3) Patients have difficulty breathing stops for 30 seconds. 4) Patients with a pacemaker embedded in the body, such as precision instruments. 5) heart failure, respiratory failure, liver failure, patients with renal insufficiency. 6) Patients with claustrophobia. 7) Patients not maintain a supine rest for 30 minutes.

Design outcomes

Primary

Measure	Time frame
eDWI, ADC values of LNs	—

Countries

Japan

Outcome results